Da Silva Jorge Santos

Companies

• MoonLake ImmunotherapeuticsBoard member Apr 15, 2022 to now¹
• MoonLake ImmunotherapeuticsChief executive officer Apr 15, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MIMoonLake Immunotherapeutics MLTX2,774,893 shares²$27.0M at $9.72Jul 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 10, 2026Sold 68,289 shares at $20.02 of MoonLake Immunotherapeutics²
• Jul 9, 2026Sold 33,936 shares at $20.01 of MoonLake Immunotherapeutics²
• Jul 1, 2026Sold 47,775 shares at $20.03 of MoonLake Immunotherapeutics³
• Apr 13, 2026Sold 51,873 shares at $18.23 of MoonLake Immunotherapeutics⁴
• Apr 10, 2026Sold 98,127 shares at $18.41 of MoonLake Immunotherapeutics⁴
• Dec 19, 2025Returned to company 196,316 shares of MoonLake Immunotherapeutics⁵
• Dec 19, 2025Converted 196,316 shares of MoonLake Immunotherapeutics⁵
• Dec 9, 2025Sold 70,000 shares at $14.49 of MoonLake Immunotherapeutics⁶
• Dec 8, 2025Sold 130,000 shares at $15.08 of MoonLake Immunotherapeutics⁶
• Feb 27, 2025Granted 95,763 shares of MoonLake Immunotherapeutics⁷
• Feb 29, 2024Sold 4,740 shares at $55.89 of MoonLake Immunotherapeutics⁸
• Feb 28, 2024Sold 56,065 shares at $55.00 of MoonLake Immunotherapeutics⁸
• Feb 27, 2024Sold 62,810 shares at $55.00 of MoonLake Immunotherapeutics⁸
• Feb 21, 2024Sold 1,125 shares at $55.27 of MoonLake Immunotherapeutics⁹
• Feb 20, 2024Sold 20,000 shares at $57.44 of MoonLake Immunotherapeutics¹⁰
• Feb 16, 2024Sold 20,000 shares at $60.15 of MoonLake Immunotherapeutics¹⁰
• Feb 15, 2024Sold 20,000 shares at $60.18 of MoonLake Immunotherapeutics¹⁰
• Oct 1, 2023Returned to company 140,071 shares of MoonLake Immunotherapeutics¹¹
• Oct 1, 2023Converted 140,071 shares of MoonLake Immunotherapeutics¹¹
• Oct 1, 2023Returned to company 3,027,483 shares of MoonLake Immunotherapeutics¹¹
• Oct 1, 2023Converted 3,027,483 shares of MoonLake Immunotherapeutics¹¹